Coordinatore | MEDTRONIC IBERICA SA
Organization address
address: CALLE MARIA DE PORTUGAL 11 contact info |
Nazionalità Coordinatore | Spain [ES] |
Totale costo | 11˙419˙530 € |
EC contributo | 8˙100˙000 € |
Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
Funding Scheme | CP |
Anno di inizio | 2008 |
Periodo (anno-mese-giorno) | 2008-01-01 - 2011-06-30 |
# | ||||
---|---|---|---|---|
1 |
MEDTRONIC IBERICA SA
Organization address
address: CALLE MARIA DE PORTUGAL 11 contact info |
ES (MADRID) | coordinator | 0.00 |
2 |
AZIENDA UNITA SANITARIA LOCALE DI MODENA
Organization address
address: VIA S. GIOVANNI DEL CANTONE 23 contact info |
IT (MODENA) | participant | 0.00 |
3 |
D.D. SYNERGY HELLAS ANONYMI EMPORIKI ETAIREIA PAROCHIS YPIRESION PLIROFORIKIS
Organization address
address: ODOS KREONTOS 25 contact info |
EL (ATHINA) | participant | 0.00 |
4 |
FERRARI SOCIETA PER AZIONI ESERCIZIO FABBRICHE AUTOMOBILI E CORSE O SEMPLICEMENTE: FERRARI S.P.A.
Organization address
address: VIA EMILIA EST 1163 contact info |
IT (MODENA) | participant | 0.00 |
5 |
HOSPITAL CLINICO SAN CARLOS DE MADRID INSALUD
Organization address
address: LUGAR CIUDAD UNIVERSI contact info |
ES (MADRID) | participant | 0.00 |
6 |
IDS SCHEER CR S.R.O.
Organization address
address: VIDENSKA 546/55 contact info |
CZ (BRNO) | participant | 0.00 |
7 |
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS
Organization address
address: PATISSION STREET 42 contact info |
EL (ATHINA) | participant | 0.00 |
8 |
KUOPION YLIOPISTO
Organization address
address: Yliopistonranta 1E contact info |
FI (KUOPIO) | participant | 0.00 |
9 |
MEDMARK SRO
Organization address
address: TUREKA 36 contact info |
SK (NOVE ZAMKY) | participant | 0.00 |
10 |
MEGA ELEKTRONIIKKA OY
Organization address
address: MICROKATU 1 contact info |
FI (KUOPIO) | participant | 0.00 |
11 |
MICRODATA PROIGMENI TECHNOLOGIA AE
Organization address
address: ODOS GRAVIAS 10-12 contact info |
EL (ATHINA) | participant | 0.00 |
12 |
ORT FRANCE
Organization address
address: 10 VILLA D'EYLAU contact info |
FR (PARIS) | participant | 0.00 |
13 |
R&S INFO S.R.L.
Organization address
address: BORGO PIETRO GIORDANI 8 contact info |
IT (PARMA) | participant | 0.00 |
14 |
S.A.T.E. - SYSTEMS AND ADVANCED TECHNOLOGIES ENGINEERING S.R.L.
Organization address
address: SESTIERE SANTA CROCE 664A contact info |
IT (VENEZIA) | participant | 0.00 |
15 |
SWORD TECHNOLOGIES SA
Organization address
address: 105 ROUTE D'ARLON contact info |
LU (STRASSEN) | participant | 0.00 |
16 |
UNIVERSIDAD POLITECNICA DE MADRID
Organization address
address: AVENIDA RAMIRO DE MAEZTU 7 contact info |
ES (MADRID) | participant | 0.00 |
17 |
UNIVERSIDAD POLITECNICA DE VALENCIA
Organization address
address: Camino de Vera s/n contact info |
ES (VALENCIA) | participant | 0.00 |
18 |
UNIVERSITA DEGLI STUDI DI PARMA
Organization address
address: VIA UNIVERSITA 12 contact info |
IT (PARMA) | participant | 0.00 |
19 |
UNIVERSITAET AUGSBURG
Organization address
address: UNIVERSITAETSSTRASSE 2 contact info |
DE (AUGSBURG) | participant | 0.00 |
20 |
UNIVERSITY OF PATRAS
Organization address
address: RION PATRAS contact info |
EL (PATRAS) | participant | 0.00 |
21 |
UNIVERZITA KARLOVA V PRAZE
Organization address
address: OVOCNY TRH 5 contact info |
CZ (PRAHA 1) | participant | 0.00 |
22 |
WORLD MATCH LIMITED
Organization address
address: PORTICO BUILDING, MARINA STREET contact info |
MT (PIETA) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
The aim of METABO is to set up a comprehensive platform, running both in clinical settings and in every-day life environments, for continuous and multi-parametric monitoring of the metabolic status in patients with, or at risk of, diabetes and associated metabolic disorders.
The type of parameters that will be monitored, in addition to 'traditional' clinical and biomedical parameters, will also include subcutaneous glucose concentration, dietary habits, physical activity and energy expenditure, effects of ongoing treatments, and autonomic reactions.
The data produced by METABO will be integrated with the clinical data and the history of the patient and will be used in two major interrelated contexts of care: 1. Setting up a dynamic model of the metabolic behaviour of the individual to predict the influence and relative impact of specific treatments and of single parameters on glucose level. 2. Building personalized care plans integrated in the current clinical processes linking the different actors in primary and secondary care and improving the active role of the Patient.